Prasugrel and cancer: an uncertain association or a credible risk that meaningfully alters the benefit-risk balance.
Kaul
Sanjay
S
Diamond
George A
GA
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000601:surgery; D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D015179:Colorectal Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D051379:Mice; D009203:Myocardial Infarction / Q000517:prevention & control; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000453:epidemiology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D000068799:Prasugrel Hydrochloride; D011300:Preoperative Care; D058919:Purinergic P2 Receptor Antagonists; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
D010879:Piperazines; D058919:Purinergic P2 Receptor Antagonists; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride